77 related articles for article (PubMed ID: 19446718)
1. Chemokines in human breast tumor cells: modifying their expression levels and determining their effects on the malignancy phenotype.
Soria G; Meshel T; Ben-Baruch A
Methods Enzymol; 2009; 460():3-16. PubMed ID: 19446718
[TBL] [Abstract][Full Text] [Related]
2. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Soria G; Yaal-Hahoshen N; Azenshtein E; Shina S; Leider-Trejo L; Ryvo L; Cohen-Hillel E; Shtabsky A; Ehrlich M; Meshel T; Keydar I; Ben-Baruch A
Cytokine; 2008 Oct; 44(1):191-200. PubMed ID: 18790652
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
5. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
[TBL] [Abstract][Full Text] [Related]
6. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21.
Skelding KA; Barry RD; Shafren DR
Breast Cancer Res Treat; 2009 Jan; 113(1):21-30. PubMed ID: 18256929
[TBL] [Abstract][Full Text] [Related]
7. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
Opdenakker G; Van Damme J
Int J Dev Biol; 2004; 48(5-6):519-27. PubMed ID: 15349826
[TBL] [Abstract][Full Text] [Related]
8. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
10. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
11. Defining the molecular biology of inflammatory breast cancer.
Charafe-Jauffret E; Tarpin C; Viens P; Bertucci F
Semin Oncol; 2008 Feb; 35(1):41-50. PubMed ID: 18308145
[TBL] [Abstract][Full Text] [Related]
12. The multifaceted roles of chemokines in malignancy.
Ben-Baruch A
Cancer Metastasis Rev; 2006 Sep; 25(3):357-71. PubMed ID: 17016763
[TBL] [Abstract][Full Text] [Related]
13. GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells.
Cazet A; Groux-Degroote S; Teylaert B; Kwon KM; Lehoux S; Slomianny C; Kim CH; Le Bourhis X; Delannoy P
Biol Chem; 2009 Jul; 390(7):601-9. PubMed ID: 19335207
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
15. [Growing characteristic of breast adenocarcinoma suicide gene cell line T47D-tk and construction of subcutaneous xenografts].
Xu WG; Yang K; Fang N; Dai D; Yu JP; Wei F; Song XY; Zhu YJ; Wang J; Men XY; Zhang Y
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):423-6. PubMed ID: 19567126
[TBL] [Abstract][Full Text] [Related]
16. Eotaxin-2 and colorectal cancer: a potential target for immune therapy.
Cheadle EJ; Riyad K; Subar D; Rothwell DG; Ashton G; Batha H; Sherlock DJ; Hawkins RE; Gilham DE
Clin Cancer Res; 2007 Oct; 13(19):5719-28. PubMed ID: 17908961
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.
Yin Y; Chen X; Shu Y
Biomed Pharmacother; 2009 Jul; 63(6):421-8. PubMed ID: 19564093
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
[TBL] [Abstract][Full Text] [Related]
19. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
